Senior insider sale
Chief Executive Officer at ITEOS THERAPEUTICS, INC. — senior position signals high conviction
$526.0K
52.28K shares
What this filing means
DETHEUX MICHEL plans to sell 52.28K shares of ITEOS THERAPEUTICS, INC. valued at approximately $526.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/4/2025ACC: 0001969223-25-000396
DirectorOfficer· Chief Executive Officer
Since Jul 2020
52.28K
Shares to sell
$526.0K
Approx. market value
52.28K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
6/4/2025
52.28KTotal acquired52.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2025 | Exercise of Stock Options Cash | 52.28K | — |
| Total | 52.28K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
52.28K
Market value
$526.0K
6/4/2025
Total
Units
52.28K
Value
$526.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/4/2025 | 52.28K | $526.0K | Nasdaq | Planned |
| Total | 52.28K | $526.0K | ||